Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study-Reference-Cited by-同舟云学术

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer’s Disease: The OmegAD Study

Published:2019-05-07 Issue:1 Volume:69 Page:189-197
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Jernerén Fredrik¹,Cederholm Tommy²³,Refsum Helga⁴⁵,Smith A. David⁵,Turner Cheryl⁵,Palmblad Jan⁶,Eriksdotter Maria³⁷,Hjorth Erik⁷,Faxen-Irving Gerd⁷,Wahlund Lars-Olof⁷,Schultzberg Marianne⁷,Basun Hans²,Freund-Levi Yvonne⁷⁸⁹¹⁰

Affiliation:

1. Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

2. Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden

3. Theme Ageing, Karolinska University Hospital, Stockholm, Sweden

4. Department of Nutrition, University of Oslo, Oslo, Norway

5. Department of Pharmacology, University of Oxford, Oxford, United Kingdom

6. Departments of Medicine and Hematology, Karolinska University Hospital Huddinge, and the Karolinska Institutet, Stockholm, Sweden

7. Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden

8. Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden

9. Department of Psychiatry in Region Örebro County and School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro

10. Department of Old Age Psychiatry, Psychology & Neuroscience, King’s College, London, UK

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference30 articles.

1. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer’s disease: The OmegAD study;Freund Levi;J Intern Med,2014

2. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain;Crawford;Lipids,1999

3. Distribution, interconversion, and dose response of n-3 fatty acids in humans;Arterburn;Am J Clin Nutr,2006

4. Homocysteine, B vitamins, and cognitive impairment;Smith;Annu Rev Nutr,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing cognitive function in older adults: dietary approaches and implications;Frontiers in Nutrition;2024-01-31

2. Alzheimer’s disease risk reduction in clinical practice: a priority in the emerging field of preventive neurology;Nature Mental Health;2024-01-10

3. Unraveling the impact of Omega-3 polyunsaturated fatty acids on blood-brain barrier (BBB) integrity and glymphatic function;Brain, Behavior, and Immunity;2024-01

4. Gut microbiome-targeted therapies for Alzheimer’s disease;Gut Microbes;2023-11-07

5. Quantitative Profiling Method for Oxylipins in Neurodegenerative Diseases by Liquid Chromatography Coupled with Tandem Mass Spectrometry;2023-10-03